APA (7th ed.) Citation

N, J., J, T., NJ, B., KV, G., RA, L., AJ, T., . . . S, Y. (2025). Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience. Clinical breast cancer, 25(3), e211. https://doi.org/10.1016/j.clbc.2024.10.006

Chicago Style (17th ed.) Citation

N, Jahan, et al. "Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience." Clinical Breast Cancer 25, no. 3 (2025): e211. https://doi.org/10.1016/j.clbc.2024.10.006.

MLA (9th ed.) Citation

N, Jahan, et al. "Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience." Clinical Breast Cancer, vol. 25, no. 3, 2025, p. e211, https://doi.org/10.1016/j.clbc.2024.10.006.